Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/24204
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Verstockt, B. | - |
dc.contributor.author | ARIJS, Ingrid | - |
dc.contributor.author | de Bruyn, M. | - |
dc.contributor.author | Verstockt, S. | - |
dc.contributor.author | Van Assche, G. | - |
dc.contributor.author | Breynaert, C. | - |
dc.contributor.author | Vermeire, S. | - |
dc.contributor.author | Ferrante, M. | - |
dc.date.accessioned | 2017-08-11T08:44:36Z | - |
dc.date.available | 2017-08-11T08:44:36Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | JOURNAL OF CROHNS & COLITIS, 11, p. S96-S97 (Art N° P035) | - |
dc.identifier.issn | 1873-9946 | - |
dc.identifier.uri | http://hdl.handle.net/1942/24204 | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.title | TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | S97 | - |
dc.identifier.spage | S96 | - |
dc.identifier.volume | 11 | - |
local.format.pages | 2 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | [Verstockt, B.; Arijs, I.; de Bruyn, M.; Van Assche, G.; Vermeire, S.; Ferrante, M.] Katholieke Univ Leuven, Dept Clin & Expt Med, TARGID IBD, Leuven, Belgium. [Verstockt, B.] Univ Cambridge, Sch Clin Med, Dept Med, Biomed Campus, Cambridge, England. [Verstockt, B.] Cambridge Inst Med Res, Cambridge, England. [Arijs, I.] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium. [Arijs, I.] Jessa Hosp, Hasselt, Belgium. [de Bruyn, M.] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium. [Verstockt, S.] Katholieke Univ Leuven, Lab Complex Genet, Dept Human Genet, Leuven, Belgium. [Van Assche, G.; Vermeire, S.; Ferrante, M.] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium. [Breynaert, C.] Katholieke Univ Leuven, Clin Immunol Lab, Dept Microbiol & Immunol, Leuven, Belgium. | - |
local.publisher.place | OXFORD | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
local.bibliographicCitation.artnr | P035 | - |
local.class | dsPublValOverrule/author_version_not_expected | - |
dc.identifier.isi | 000398606900163 | - |
dc.identifier.url | https://www.ecco-ibd.eu/index.php/publications/congress-abstract-s/abstracts-2017/item/p035-tnf-driven-pathways-are-increased-at-baseline-in-crohn-s-disease-patients-not-responding-to-infliximab.html | - |
item.fulltext | With Fulltext | - |
item.fullcitation | Verstockt, B.; ARIJS, Ingrid; de Bruyn, M.; Verstockt, S.; Van Assche, G.; Breynaert, C.; Vermeire, S. & Ferrante, M. (2017) TNF-driven pathways are increased at baseline in Crohn's disease patients not responding to infliximab. In: JOURNAL OF CROHNS & COLITIS, 11, p. S96-S97 (Art N° P035). | - |
item.contributor | Verstockt, B. | - |
item.contributor | ARIJS, Ingrid | - |
item.contributor | de Bruyn, M. | - |
item.contributor | Verstockt, S. | - |
item.contributor | Van Assche, G. | - |
item.contributor | Breynaert, C. | - |
item.contributor | Vermeire, S. | - |
item.contributor | Ferrante, M. | - |
item.accessRights | Open Access | - |
crisitem.journal.issn | 1873-9946 | - |
crisitem.journal.eissn | 1876-4479 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
P035 TNF.pdf | Published version | 288.95 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.